Karissa Adkins

584 total citations
22 papers, 269 citations indexed

About

Karissa Adkins is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Karissa Adkins has authored 22 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Karissa Adkins's work include Asthma and respiratory diseases (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Karissa Adkins is often cited by papers focused on Asthma and respiratory diseases (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Karissa Adkins collaborates with scholars based in United States, Germany and United Kingdom. Karissa Adkins's co-authors include Hong Wu, John W. Bloom, Roger L. Miesfeld, Tricia D. LeVan, Payal Rana, Gregory C. Luerman, Dietmar Hess, Merrie Mosedale, C. Lisa Kurtz and Darin P. O’Brien and has published in prestigious journals such as Nature Reviews Drug Discovery, Vaccine and Toxicology and Applied Pharmacology.

In The Last Decade

Karissa Adkins

22 papers receiving 259 citations

Peers

Karissa Adkins
Keith M. Goldstein United States
Hyeon‐Jun Shin South Korea
Byung-Il Yoon South Korea
Dae-Yeon Lee South Korea
Karissa Adkins
Citations per year, relative to Karissa Adkins Karissa Adkins (= 1×) peers Heike Marxfeld

Countries citing papers authored by Karissa Adkins

Since Specialization
Citations

This map shows the geographic impact of Karissa Adkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karissa Adkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karissa Adkins more than expected).

Fields of papers citing papers by Karissa Adkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karissa Adkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karissa Adkins. The network helps show where Karissa Adkins may publish in the future.

Co-authorship network of co-authors of Karissa Adkins

This figure shows the co-authorship network connecting the top 25 collaborators of Karissa Adkins. A scholar is included among the top collaborators of Karissa Adkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karissa Adkins. Karissa Adkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beilmann, Mario, Karissa Adkins, Harrie C. M. Boonen, et al.. (2025). Application of new approach methodologies for nonclinical safety assessment of drug candidates. Nature Reviews Drug Discovery. 24(9). 705–725. 7 indexed citations
2.
Poisson, Louis, et al.. (2024). Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assay. Journal of Immunotoxicology. 21(sup1). S29–S37. 1 indexed citations
3.
Rusyn, Ivan, Courtney Sakolish, Yuki Kato, et al.. (2022). Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium. Toxicological Sciences. 188(2). 143–152. 27 indexed citations
4.
Finley, James E., Anna K. Kopec, Petra Koza‐Taylor, et al.. (2020). An in vitro alveolar epithelial cell model recapitulates LRRK2 inhibitor-induced increases in lamellar body size observed in preclinical models. Toxicology in Vitro. 70. 105012–105012. 6 indexed citations
5.
Sellers, Rani S., Keith Nelson, Bindu Bennet, et al.. (2019). Scientific and Regulatory Policy Committee Points to Consider*: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists. Toxicologic Pathology. 48(2). 257–276. 14 indexed citations
6.
Cook, Jon C., Hong Wu, Michael D. Aleo, & Karissa Adkins. (2018). Principles of precision medicine and its application in toxicology. The Journal of Toxicological Sciences. 43(10). 565–577. 13 indexed citations
7.
Wu, Hong, et al.. (2017). Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs. Immunogenetics. 69(4). 241–253. 1 indexed citations
8.
Rana, Payal, et al.. (2017). Utilization of iPSC-derived human neurons for high-throughput drug-induced peripheral neuropathy screening. Toxicology in Vitro. 45(Pt 1). 111–118. 37 indexed citations
9.
Wu, Hong, et al.. (2016). Identification of MHC Haplotypes Associated with Drug-induced Hypersensitivity Reactions in Cynomolgus Monkeys. Toxicologic Pathology. 45(1). 127–133. 4 indexed citations
10.
Varshney, Avanish K., Xiaobo Wang, Yan Liu, et al.. (2015). Optimization of experimental conditions for functional in vitro characterization of humanized antibodies specific for staphylococcal enterotoxin B. International Immunopharmacology. 28(1). 354–358. 6 indexed citations
11.
Church, Rachel J., Hong Wu, Merrie Mosedale, et al.. (2014). A Systems Biology Approach Utilizing a Mouse Diversity Panel Identifies Genetic Differences Influencing Isoniazid-Induced Microvesicular Steatosis. Toxicological Sciences. 140(2). 481–492. 42 indexed citations
12.
Mosedale, Merrie, et al.. (2014). Dysregulation of protein degradation pathways may mediate the liver injury and phospholipidosis associated with a cationic amphiphilic antibiotic drug. Toxicology and Applied Pharmacology. 280(1). 21–29. 11 indexed citations
13.
Wu, Hong & Karissa Adkins. (2012). Identification of polymorphisms in genes of the immune system in cynomolgus macaques. Mammalian Genome. 23(7-8). 467–477. 6 indexed citations
14.
Wright, David J., et al.. (2012). Reproductive Performance and Early Postnatal Development in Interleukin (IL)‐13‐Deficient Mice. Birth Defects Research Part B Developmental and Reproductive Toxicology. 95(5). 346–353. 1 indexed citations
15.
Arai, Maya, Andrew A. Hill, Yongjing Guo, et al.. (2010). Development and application of a biomarker assay for determining the pharmacodynamic activity of an antagonist candidate biotherapeutic antibody to IL21R in whole blood. Journal of Translational Medicine. 8(1). 51–51. 6 indexed citations
16.
Vugmeyster, Yulia, Scott W. Allen, Pamela Szklut, et al.. (2010). Correlation of pharmacodynamic activity, pharmacokinetics, and anti-product antibody responses to anti-IL-21R antibody therapeutics following IV administration to cynomolgus monkeys. Journal of Translational Medicine. 8(1). 41–41. 15 indexed citations
17.
Kowalski, Jacek, Karissa Adkins, Heather Arendt, et al.. (2006). Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D. Vaccine. 25(12). 2296–2305. 8 indexed citations
18.
Adkins, Karissa, et al.. (2002). Utilizing Genomic DNA Purified From Clotted Blood Samples for Single Nucleotide Polymorphism Genotyping. Archives of Pathology & Laboratory Medicine. 126(3). 266–270. 11 indexed citations
19.
Adkins, Karissa, et al.. (2002). Utilizing genomic DNA purified from clotted blood samples for single nucleotide polymorphism genotyping.. Archives of Pathology & Laboratory Medicine. 126(3). 266–70. 10 indexed citations
20.
Adkins, Karissa, Tricia D. LeVan, Roger L. Miesfeld, & John W. Bloom. (1998). Glucocorticoid regulation of GM-CSF: evidence for transcriptional mechanisms in airway epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 275(2). L372–L378. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026